Oral Anticoagulation: Reversing the Current View in Bleeding Events
Advances in new reversal agents will be key for managing patients treated with DOACs to prevent major bleeding events.
All articles by Zachary R. Lavender, PA-C, MHS; Peter S. Sandor, RRT, MHS, PA-C, DFAAPA
Next post in Features
